Cannara Biotech Financial Overview
Cannara Biotech's market cap is currently $121.06M. The company's EPS TTM is $0.029029560000000003; its P/E ratio is 12.35; Cannara Biotech is scheduled to report earnings on November 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
